PATENT CLAIM ANALYSIS

Application Number: 16001247
Application Type: Utility
Filing Date: 2018-06
Publication Date: 2018-12
Patent Classification: ["514", "221000"]

Abstract:
The present invention discloses compounds of Formula (I), and pharmaceutically acceptable salts, esters, or prodrugs thereof: which inhibit Respiratory Syncytial Virus (RSV). The present invention further relates to pharmaceutical compositions comprising the aforementioned compounds for administration to a subject suffering from RSV infection. The invention also relates to methods of treating an RSV infection in a subject by administering a pharmaceutical composition comprising the compounds of the present invention.

Claim (Index 11):
A pharmaceutical composition comprising a compound according to  claim 1 , in combination with a pharmaceutically acceptable carrier, diluent or excipient.

Metadata:
- Claim Count in Document: 21.0
- Percentile: 94.0
- Lexical Diversity: 1.6
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15216119', '15863216', '15914016', '11503502', '12108624']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.790203692456638
- 35 USC 102 Novelty (BERT): 0.5319646390240211
- Combined Prediction Score: 0.7643797871133763
- Mean Citation Score: 336.74302
- Max Citation Score: 367.8282
- Similarity Product: 312.16085810687537

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test